Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 5;20(1):569-78.
doi: 10.2119/molmed.2014.00176.

Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain

Affiliations
Review

Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain

Nilesh M Agalave et al. Mol Med. .

Abstract

Although originally described as a highly conserved nuclear protein, high-mobility group box 1 protein (HMGB1) has emerged as a danger-associated molecular pattern molecule protein (DAMP) and is a mediator of innate and specific immune responses. HMGB1 is passively or actively released in response to infection, injury and cellular stress, providing chemotactic and cytokine-like functions in the extracellular environment, where it interacts with receptors such as receptor for advanced glycation end products (RAGE) and several Toll-like receptors (TLRs). Although HMGB1 was first revealed as a key mediator of sepsis, it also contributes to a number of other conditions and disease processes. Chronic pain arises as a direct consequence of injury, inflammation or diseases affecting the somatosensory system and can be devastating for the affected patients. Emerging data indicate that HMGB1 is also involved in the pathology of persistent pain. Here, we give an overview of HMGB1 as a proinflammatory mediator, focusing particularly on the role of HMGB1 in the induction and maintenance of hypersensitivity in experimental models of pain and discuss the therapeutic potential of targeting HMGB1 in conditions of chronic pain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HMGB1 induces pain-like behavior in rodents. (A) Injection of recombinant HMGB1 to the paw, ankle joint, sciatic nerve or intrathecal space evokes pain-like behavior in rodents. (B) The structure of HMGB1 with the two DNA binding domains (the A and B boxes), the acidic C-terminal tail and nuclear location signals (NLSs) outlined. The three cysteine residues that are important for functional activity of HMGB1 are highlighted. (C) Graph shows that intraarticular (i.a.) injection of 1 μg disulfide HMGB1, but not saline, induces mechanical hypersensitivity in male Balb/c mice 6 h after injection. Mechanical sensitivity is assessed by von Frey filaments, and data are presented as threshold (g) with 50% probability of response. Data represents mean ± standard error of the mean. n = 5/group. **p < 0.001.

References

    1. Ueda T, Yoshida M. HMGB proteins and transcriptional regulation. Biochim Biophys Acta. 2010;1799:114–8. - PubMed
    1. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139–62. - PMC - PubMed
    1. Harris HE, Andersson U, Pisetsky DS. HMGB1: a multifunctional alarmin driving auto-immune and inflammatory disease. Nat Rev Rheumatol. 2012;8:195–202. - PubMed
    1. Park JS, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279:7370–7. - PubMed
    1. van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) Angiogenesis. 2008;11:91–9. - PubMed